Steven J Warach1,2, Jeffrey L Saver3. Show Affiliations » 1. Department of Neurology, Dell Medical School, University of Texas at Austin, Austin. 2. Ascension Texas, Austin. 3. Department of Neurology, Geffen School of Medicine at UCLA, Los Angeles, California.
Abstract
Entities: Disease
Mesh: See more » COVID-19/complicationsCOVID-19/prevention & controlEmergency Service, Hospital/standardsFibrinolytic Agents/administration & dosageFibrinolytic Agents/supply & distributionHumansTenecteplase/administration & dosageTenecteplase/supply & distributionThrombolytic Therapy/standardsThrombosis/drug therapyTissue Plasminogen Activator/administration & dosageTissue Plasminogen Activator/supply & distributionWorkflow
Substances: See more » Fibrinolytic AgentsTissue Plasminogen ActivatorTenecteplase
Year: 2020 PMID: 32687579 DOI: 10.1001/jamaneurol.2020.2396
Source DB: PubMed Journal: JAMA Neurol ISSN: 2168-6149 Impact factor: 18.302